Identification of the SARS-CoV-2 Genome in Various Systemic Samples from the Laboratory of Confirmed COVID-19 Patients in Iran
Open Access
- 9 March 2025
- journal article
- Published by Brieflands in Archives of Pediatric Infectious Diseases
- Vol. 13 (3)
Abstract
Background: COVID-19 is a highly contagious respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While nasopharyngeal swab testing remains the primary method for identifying SARS-CoV-2 carriers, the virus’s genetic material can be detected in various bodily samples, suggesting potential transmission through non-respiratory routes. Objectives: This study aimed to investigate the presence and quantity of SARS-CoV-2 RNA in stool, endotracheal tube (ETT) samples, cerebrospinal fluid (CSF), bronchoalveolar lavage (BAL), and sputum. The research sought to correlate these findings with clinical characteristics and the severity of illness. Methods: We retrospectively collected 1,567 samples, including 550 BAL samples, 464 ETT samples, 45 fecal samples, 21 CSF samples, and 487 sputum samples from patients admitted to Namazi Hospital between April 1, 2020, and the end of September 2022. Clinical characteristics, patient demographics, radiographic, and laboratory results were among the medical data gathered and assessed. We used reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect and measure SARS-CoV-2 RNA shedding in different samples of individuals infected with COVID-19. Results: Among the 550 BAL samples collected from patients, 20.7% tested positive for SARS-CoV-2. Additionally, the virus’s genome was detected in 17.8% of 45 CSF samples, 11% of 464 ETT samples, 4.76% of 21 fecal samples, and 2.9% of 487 sputum samples. Notably, patients with SARS-CoV-2-positive BAL samples exhibited a significantly higher frequency of cough and dyspnea than those who tested negative. Conclusions: These findings revealed that SARS-CoV-2 has been detected in diverse specimens collected from the upper and lower respiratory systems (sputum, ETT, and BAL samples), the central nervous system (CSF), and the digestive tract (fecal samples) during the infection’s progression. This widespread presence significantly impacts our understanding of the disease’s pathogenesis and enhances diagnostic capabilities, proving a valuable asset in managing the infection.Keywords
This publication has 30 references indexed in Scilit:
- Characterization and phylogenetic analysis of Iranian SARS‐CoV‐2 genomes: A phylogenomic studyHealth Science Reports, 2023
- A systematic review and metanalysis of diagnostic yield of BAL for detection of SARS-CoV-2Heart & Lung, 2021
- Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severityJournal of Infection, 2021
- Coronavirus Disease 2019 Test Correlation Between Nasopharyngeal Swab and BAL in Asymptomatic PatientsChest, 2021
- SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestationJournal of Neuroimmunology, 2021
- SARS‐CoV‐2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown periodJournal of Medical Virology, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcomeInfection, 2016
- Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltratesAnnals of Hematology, 2014
- Infectious pulmonary complications after stem cell transplantation or chemotherapy: Diagnostic yield of bronchoalveolar lavageDiagnostic Microbiology and Infectious Disease, 2005